Back to search

University of Southampton

Adverse events during antidepressant treatment : prescription event monitoring studies with mirtazapine and paroxetine in general medical practice in England

Abstract

dc:description.abstract

<p><span >The research described within this thesis aimed to evaluate the profile of adverse events during treatment with the antidepressant mirtazapine in general medical practice in </span><span >England</span><span >. The method employed was Prescription Event Monitoring (PEM), which is non-interventional, and provides ‘real world’ clinical data: patients included within this method are considered more representative of the wider population exposed to the drug, than patient samples included within clinical trial databases.</span></p> <p><span >Using the Drug Safety Research Unit PEM database, events reported during treatment with mirtazapine were analysed and compared with events reported with the selective serotonin reuptake inhibitor paroxetine. Incidence densities (IDs) for reported events were calculated, during the first month of treatment (ID<sub>1</sub>) and during months two to six (ID<sub>2</sub>) for mirtazapine and paroxetine, The profile of reported adverse events was compared to the description within the Summary of Product Characteristics (SPC) for mirtazapine and previously unrecognised events are described.</span></p> <p><span >The most frequently reported suspected adverse drug reactions (ADRs) were ‘unspecified’ side effects (n=177), drowsiness/sedation (116) and malaise/lassitude (71). Events with highest incidence density in the first month (ID<sub>1</sub> per 1000 patient-months treatment) were: drowsiness/sedation (58.1), malaise/lassitude (27.8) and dizziness (15.6). The most frequently reported events for stopping mirtazapine were: not effective (2432), drowsiness/sedation (800) and weight gain (362). Adverse events possibly due to mirtazapine but not included within the SPC were agitation (73), aggression (70), dizziness (122), rash (20), hallucinations (13), abnormal dreams (31), oedema (30), palpitations (10) and tremor (14).</span></p>

Degree

thesis:*
Name dc:type.qualificationname
Ph.D.
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Southampton
Year dc:date.issued
2005

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Biswas, Pipasha Nandy

Rights

Language dc:language
English, eng

Chain of custody

source
Harvested from
University of Southampton
Base URL
eprints.soton.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Biswas, Pipasha Nandy. Adverse events during antidepressant treatment : prescription event monitoring studies with mirtazapine and paroxetine in general medical practice in England. doctoral thesis, University of Southampton, 2005.